New York bills · 2025 Regular Session
New York A 500
Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Phil Steck (Democratic)
Summary
Official abstract published by the New York legislature
Establishes a generic drug research and development laboratory and production facility to manufacture generic prescription drugs in the state and the empire state biosimilar insulin initiative, which will develop generic forms of the three most widely used forms of insulin.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 7, 2026 · House
REFERRED TO HEALTH - Jan 8, 2025 · House
REFERRED TO HEALTH